High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$165K
$165,201
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
TARS
S
Tarsus Pharmaceuticals, Inc.
Lin Elizabeth Yeu
• Officer • Chief Medical Officer
Sell to Cover
2025-12-16
$165,201
|
||||||
| TARS |
Tarsus Pharmaceuticals, Inc.
|
Officer • Chief Medical Officer
Sell to Cover
|
2025-12-16 | $165,201 | S | Form 4 |
|
TARS
M
Tarsus Pharmaceuticals, Inc.
Lin Elizabeth Yeu
• Officer • Chief Medical Officer
Equity Compensation
2025-12-15
$0
|
||||||
| TARS |
Tarsus Pharmaceuticals, Inc.
|
Officer • Chief Medical Officer
Equity Compensation
|
2025-12-15 | $0 | M | Form 4 |